Holen Sie sich die Stockscreener-App
29.19
0.68%
-0.20
Handel nachbörslich:
29.77
0.58
+1.99%
Schlusskurs vom Vortag:
$29.39
Offen:
$29.39
24-Stunden-Volumen:
550.51K
Relative Volume:
1.04
Marktkapitalisierung:
$1.36B
Einnahmen:
$722.68M
Nettoeinkommen (Verlust:
$134.71M
KGV:
10.93
EPS:
2.67
Netto-Cashflow:
$109.94M
1W Leistung:
-3.54%
1M Leistung:
+36.40%
6M Leistung:
+5.68%
1J Leistung:
-37.76%
1-Tages-Spanne:
$28.88
$29.59
1-Wochen-Bereich:
$28.88
$31.26
52-Wochen-Spanne:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Vergleichen Sie AMPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
29.19 | 1.43B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Hochstufung | Needham | Hold → Buy |
| 2025-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Nuveen LLC Invests $2.77 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Tools to monitor Amphastar Pharmaceuticals Inc. recovery probabilityPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
Chart based exit strategy for Amphastar Pharmaceuticals Inc.2025 Major Catalysts & Real-Time Stock Entry Alerts - Newser
Published on: 2025-09-02 14:51:13 - Newser
How to escape a deep drawdown in Amphastar Pharmaceuticals Inc.2025 Momentum Check & Safe Capital Preservation Plans - Newser
Building trade automation scripts for Amphastar Pharmaceuticals Inc.Quarterly Growth Report & Long-Term Capital Growth Ideas - Newser
How to manage a losing position in Amphastar Pharmaceuticals Inc.Weekly Market Summary & Long-Term Growth Stock Strategies - Newser
Risk adjusted return profile for Amphastar Pharmaceuticals Inc. analyzedWeekly Market Report & Daily Profit Maximizing Trade Tips - Newser
Statistical indicators supporting Amphastar Pharmaceuticals Inc.’s strengthBull Run & Technical Pattern Recognition Alerts - Newser
What’s the recovery path for long term holders of Amphastar Pharmaceuticals Inc.2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
How hedge fund analytics apply to Amphastar Pharmaceuticals Inc. stockJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How to use a screener to detect Amphastar Pharmaceuticals Inc. breakoutsJobs Report & Smart Swing Trading Alerts - Newser
Amphastar Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Volume & Comprehensive Market Scan Reports - Newser
What recovery options are there for Amphastar Pharmaceuticals Inc.Market Performance Report & Daily Price Action Insights - Newser
Is this a good reentry point in Amphastar Pharmaceuticals Inc.Trade Exit Summary & Low Risk Profit Maximizing Plans - Newser
Will earnings trigger a reversal in Amphastar Pharmaceuticals Inc.Market Trend Summary & Reliable Intraday Trade Plans - Newser
Can Amphastar Pharmaceuticals Inc. hit a new high this monthEarnings Beat & Long-Term Growth Stock Strategies - Newser
Amphastar Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Outlook & Weekly Top Gainers Alerts - Newser
Ranking Amphastar Pharmaceuticals Inc. among high performing stocks via toolsWeekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Will Amphastar Pharmaceuticals Inc. outperform small cap indexesJuly 2025 Pullbacks & Intraday High Probability Alerts - khodrobank.com
Real time pattern detection on Amphastar Pharmaceuticals Inc. stockPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Is the Options Market Predicting a Spike in Amphastar Pharmaceuticals Stock? - TradingView
Can volume confirm reversal in Amphastar Pharmaceuticals Inc.2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Published on: 2025-09-02 04:47:08 - Newser
Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection - Yahoo Finance
American Century Companies Inc. Sells 164,024 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Live market analysis of Amphastar Pharmaceuticals Inc.Trade Exit Summary & Trade Opportunity Analysis - Newser
Published on: 2025-09-02 08:34:50 - khodrobank.com
Epoch Investment Partners Inc. Increases Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals Inc. stock chart pattern explainedEarnings Recap Report & Smart Money Movement Tracker - Newser
Can Amphastar Pharmaceuticals Inc. stock double in the next year2025 Macro Impact & Low Volatility Stock Recommendations - khodrobank.com
What analysts say about Amphastar Pharmaceuticals Inc. stockTrade Signal Summary & Free Real-Time Volume Trigger Notifications - khodrobank.com
Is Amphastar Pharmaceuticals Inc. a stock for growth or value investors2025 Top Gainers & Stock Portfolio Risk Control - khodrobank.com
Volume spikes in Amphastar Pharmaceuticals Inc. stock – what they mean2025 Earnings Impact & High Conviction Trade Alerts - Newser
What’s next for Amphastar Pharmaceuticals Inc. stockShare Buyback & Weekly Stock Performance Updates - khodrobank.com
Published on: 2025-09-01 11:27:34 - Newser
How to interpret RSI for Amphastar Pharmaceuticals Inc. stockJuly 2025 Earnings & Expert Verified Movement Alerts - Newser
Amphastar Pharmaceuticals Inc. stock volume spike explainedPortfolio Performance Report & High Return Trade Guides - Newser
Technical Heatmap Flags Amphastar Pharmaceuticals Inc. for Watch getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Amphastar Pharmaceuticals Inc. stock reversal real or fakeWeekly Earnings Recap & Verified Momentum Stock Alerts - Newser
Has Amphastar Pharmaceuticals Inc. found a price floorTrade Risk Assessment & Community Verified Trade Signals - Newser
Charles Schwab Investment Management Inc. Has $9.46 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Custom watchlist performance reports with Amphastar Pharmaceuticals Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - Newser
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyMarket Risk Summary & Technical Pattern Based Signals - Newser
Using Bollinger Bands to evaluate Amphastar Pharmaceuticals Inc.Watch List & Trade Opportunity Analysis - Newser
Exit strategy if you’re trapped in Amphastar Pharmaceuticals Inc.Earnings Risk Report & Technical Confirmation Alerts - Newser
Published on: 2025-08-31 16:00:23 - Newser
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):